Navigation Links
Friendly bacteria in chewing gum that bites back

A chewing gum containing good bacteria that can destroy the bad bacteria that cause tooth decay could be in the shops soon reports Marina Murphy in C&I. The gum is one of several products being developed by German chemical company BASF using the bacteria Lactobacillus, which is normally found in live yoghurt.

BASF discovered a new strain of lactobacillus called L. anti-caries, which binds to Strepptococcus mutans, the bacteria responsible for tooth decay. S. Mutans sticks to the surface of teeth, where it produces an aggressive acid that breaks down the enamel. The friendly bugs in the gum will make the S. Mutans clump together, preventing them from becoming attached to the tooth surface. Tests reveal that the chewing gum can reduce the amount of bacteria in the mouth fifty times.

Stefan Marcinowski, executive director of research at BASF said that a Lactobacillus product is due to hit the supermarkets in 2007, but would not confirm whether it is the chewing gum. Marcinowski says that the chewing gum 'has been tested on large numbers of people and demonstrated the ability to significantly reduce bacterial levels.' A new range of toothpastes and mouthwashes using L. anti-caries are also in the pipeline.

Chewing gums containing the artificial sweetener xylitol, which has antimicrobial properties, have also been shown to suppress the bacteria that fight tooth decay.

Other potential uses of Lactobacillus include the prevention of body odour. BASF are looking into producing a deodorant based on L. aladoris, which can inhibit odour-producing bacteria in the armpit. Similarly, tests have shown another strain, L. ala-odoris can reduce odour formation in feet.


'"/>

Source:Society of Chemical Industry


Page: 1

Related biology news :

1. Spider Venom Could Yield Eco-Friendly Insecticides
2. Friendly bacteria in humans may protect against HIV
3. Friendly bacteria in alcoholic milkshake could fight food allergies
4. Anti-bacterial additive widespread in U.S. waterways
5. A bacterial genome reveals new targets to combat infectious disease
6. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
7. Scientists discover that host cell lipids facilitate bacterial movement
8. Family trees of ancient bacteria reveal evolutionary moves
9. Drug-resistant bacteria on poultry products differ by brand
10. Programmable cells: Engineer turns bacteria into living computers
11. NASA links nanobacteria to kidney stones and other diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Biometrics Market 2017-2021" report to their offering. ... The global voice recognition biometrics ... 2017-2021. The report covers the present scenario and ... 2017-2021. To calculate the market size, the report considers the revenue ...
(Date:1/18/2017)... 18, 2017 MedNet Solutions , ... the entire spectrum of clinical research, is proud ... year for the organization in terms of corporate ... eClinical products and services. The company,s exceptional achievements ... of iMedNet ™ ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... Calif. , Feb. 17, 2017  Protagonist ... detailing data on its oral peptide drug candidates, ... Congress of the European Crohn,s and Colitis Organization ... Barcelona, Spain from February ... posters detail preclinical data on Protagonist drug candidates ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, 2017 ... on venture growth investments in biotechnology and medical ... Richardson , M.D. to Managing Director. ... He is a board observer at InfaCare Pharmaceutical ... investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence Pharmaceuticals ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
Breaking Biology Technology: